Furthermore, we demonstrated that the levels of miR-146a can distinguish between cirrhotic patients with and without HCC with a ROC/AUC of 0.80, comparable to the established tumor marker AFP (ROC/AUC: 0.83) [42]. The gene discussed is AFP; the disease is hepatocellular carcinoma.